Ardelyx. has been granted a patent for compounds and methods aimed at treating fluid retention disorders, hypertension, and gastrointestinal issues. The approach involves administering compounds that inhibit specific sodium and hydrogen ion transporters in the GI tract, minimizing systemic absorption and targeting treatment effectively. GlobalData’s report on Ardelyx gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Ardelyx, Peptide pharmacophores was a key innovation area identified from patents. Ardelyx's grant share as of July 2024 was 39%. Grant share is based on the ratio of number of grants to total number of patents.
Compounds for treating fluid retention and gastrointestinal disorders
The granted patent US12016856B2 pertains to a specific compound or its pharmaceutically acceptable salt, characterized by a defined chemical formula. The claims emphasize the structural integrity of the compound, which is central to its potential applications in pharmaceutical formulations. The patent also specifies that the compound can exist in the form of its free base, indicating a particular state of the compound that may have distinct properties or benefits in therapeutic contexts.
The claims highlight the versatility of the compound, allowing for both its salt form and free base form to be utilized in various pharmaceutical applications. This flexibility may enhance the compound's efficacy, stability, or bioavailability, making it a valuable addition to the field of medicinal chemistry. The patent's focus on these specific forms underscores the importance of chemical structure in the development of new therapeutic agents.
To know more about GlobalData’s detailed insights on Ardelyx, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
